Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 3, May-June, p. 393–399

doi: 10.17219/acem/29181

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

C4d Deposition Reveals Myocardial Infarction After Cardiac Arrest – Experimental Study

Vilma Vuohelainen1,A,B,D,F, Timo Paavonen2,A,E,F, Mari Hamalainen3,B,C,D,E,F, Eeva Moilanen3,A,C,D,E,F, Ari A. Mennander1,A,B,C,D,E,F

1 Heart Hospital, Tampere University Hospital, Tampere, Finland

2 Department of Pathology, Tampere University Hospital, Tampere, Finland

3 Department of Immunopharmacology, Tampere University, Tampere, Finland

Abstract

Background. . The diagnosis of regional myocardial infarction (MI) after cardiac arrest and ischemia-reperfusion injury (IRI) is a major clinical challenge.
Objectives. We evaluated in a rat cardiac transplantation model whether IRI alone or with MI would induce complement C4d deposition.
Material and Methods. Isogenic heterotopic cardiac transplantation was performed in 16 Fischer 344 rats to induce IRI, of which 9 rats also underwent ligation of the left anterior coronary artery (LAD) of the heart to yield MI. Histology and qRT-PCR for endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS) and transforming growth factor β (TGFβ) were performed after cessation of heart beat. C4d was evaluated by immunohistochemistry.
Results. Myocardial inflammation and C4d deposition was increased in grafts with IRI+MI as compared with IRI (0.71 vs. 0.14, PSU, respectively, p < 0.04 and 80.13 vs. 20.29, PSU, respectively, p < 0.02). The expression of eNOS decreased in grafts with IRI + MI as compared with IRI (p < 0.05). Receiver operating characteristic (ROC) curve analysis showed that IRI + MI was associated with C4d deposition (AUC 0.837; S.E. 0.116; p = 0.035; 95% C.I. 0.610–1.000).
Conclusion. Increased C4d deposition may be amenable to identify early MI after cardiac arrest. Early treatment aimed towards complement activation may provide a novel means for induced MI after cardiac arrest.

Key words

myocardial infarction, C4d, complement, heterotopic rat cardiac transplantation.

References (24)

  1. Nijmeijer R, Krijnen PA, Assink J, Klaarenbeek MA, Lagrand WK, Veerhuis R, Visser CA, Meijer CJ, Niessen HW, Hack CE: C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest 2004, 34, 803–810.
  2. Tello-Montoliu A, Marin F, Roldan V, Mainar L, Lopez MT, Sogorb F, Vicente V, Lip GY: A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT proBNP and fibrin D-dimer levels. J Intern Med 2007, 262, 651–658.
  3. Levi M, van der Poll T, Buller HR: Bidirectional relation between inflammation and coagulation. Circulation 2004, 109, 2698–2704.
  4. Vuohelainen V, Raitoharju E, Levula M, Lehtimaki T, Pelto-Huikko M, Honkanen T, Huovila A, Paavonen T, Tarkka M, Mennander A: Myocardial infarction induces early increased remote ADAM8 expression of rat hearts after cardiac arrest. Scand J Clin Lab Invest 2011, 71, 553–562.
  5. Mathey D, Schofer J, Schäfer HJ, Hamdoch T, Joachim HC, Ritgen A, Hugo F, Bhakdi S: Early accumulation of the terminal complement-complex in the ischemic myocardium after reperfusion. Eur Heart J 1994, 15, 418–423.
  6. Amsterdam EA, Stahl GL, Pan HL, Rendig SV, Fletcher MP, Longhurst JC: Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am J Physiol 1995, 268, 448–457.
  7. Ganter MT, Brohi K, Cohen MJ, Shaffer LA, Walsh MC, Stahl GL, Pittet JF: Role of the alternative pathway in the early complement activation following major trauma. Shock 2007, 28, 29–34.
  8. Niinimaki E, Paavonen T, Valo T, Tarkka M, Mennander A: Lack of C4d deposition may reveal susceptibility for ascending aortic dissection. Scand Cardiovasc J 2012, 46, 177–182.
  9. Rensen SS, Slaats Y, Driessen A, Peutz-Koostra CJ, Nijhuis J, Steffensen R, Greve JW, Buurman WA: Activation of complement system in human nonalcoholic fatty liver disease. Hepatology 2009, 50, 1809–1817.
  10. Széplaki G, Hirschberg K, Gombos T, Varga L, Prohaszka Z, Dosa E, Acsady G, Karadi I, Garred P, Entz L, Fust G: Early complement activation follows eversion carotid endarterectomy and correlates with the time of clamping of the carotid artery. Mol Immunol 2008, 45, 3289–3294.
  11. Jenkins CP, Cardona DM, Bowers JN, Oliai BR, Allan RW, Normann SJ: The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction. Arch Pathol Lab Med 2010, 134, 256–263.
  12. Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simkins CE, Leplev D, King KE, Kraus ES, Montgomery RA: C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2009, 20, 197–204.
  13. Fraser DA, Tenner AJ: Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages. J Immunol 2010, 1, 3932–3939.
  14. Yang C, Talukder MA, Varadharaj S, Velayutham M, Zweier JL: Early ischemic preconditioning requires Aktand PKA-mediated activation of eNOS via serine1176 phosphorylation. Cardiovasc Res 2013, 97, 33–43.
  15. Ricci D, Mennander AA, Miyagi N, Rao VP, Tazelaar HD, Classik K, Byrne GW, Russell SJ, McGregor CG: Prolonged cardiac allograft survival using iodine 131 after human sodium iodide symporter gene transfer in a rat model. Transplant Proc 2010, 42, 1888–1894.
  16. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-∆∆Ct method. Methods 2001, 25, 402–408.
  17. Yasojima K, Schwab C, McGeer EG, McGeer PL: Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res 1998, 83, 860–869.
  18. Shields KJ, Stolz D, Watkins SC, Ahearn JM: Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis. Clin Trans Sci 2011, 4, 146–152.
  19. Yasojima K, Kilgore KS, Washington RA, Lucchesi BR, McGeer PL: Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion. Circ Res 1998, 82, 1224–1230.
  20. Minami K, Murata K, Lee CY, Fox-Talbot K, Wasowska BA, Pescovitz MD, Baldwin WM 3rd: C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006, 6, 923–932.
  21. Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA: Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. Transpl Immunol 2012, 26, 63–69.
  22. Hudacko R, Varghese S, Fyfe B: Pattern and evolution of C4d staining of ischemic myocardial injury: implications for the interpretation of post-transplant endomyocardial biopsies. N A J Med Sci 2012, 5, 64–70.
  23. ter Weeme M, Vonk AB, Kupreishvili K, van Ham M, Zeerleder S, Wouters D, Stooker W, Eijsman L, van Hinsbergh VW, Krijnen PA, Niessen HW: Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation. Eur J Clin Invest 2010, 40, 4–10.
  24. Miller DV, Roden AC, Gamez JD, Tazelaar HD: Detection of C4d deposition in cardiac allografts: a comparative study of immunofluorescence and immunoperoxidase methods. Arch Pathol Lab Med 2010, 134, 1679–1684.